Literature DB >> 7902061

Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.

K Shiga1, C Shiga, H Sasano, S Miyazaki, T Yamamoto, M Yamamoto, N Hayashi, T Nishihira, S Mori.   

Abstract

Amplification and expression of the c-erbB-2 protooncogene was studied in 60 primary human esophageal carcinomas and 12 cell lines established from the carcinomas. Amplification of the c-erbB-2 gene was found in 4 out of 60 (6.7%) and 1 out of 12 (8.3%) DNA samples from the primary carcinomas and cell lines, respectively. Overexpression of c-erbB-2 gene product, as determined by both Northern blot hybridization and immunohistochemical analysis, was found in the cells with c-erbB-2 amplification, but not in normal esophageal mucosae or in primary esophageal carcinomas without gene amplification. In contrast, c-erbB-2 overexpression was clearly observed in 7 cell lines in which gene amplification was not found. We analyzed expression of the GATA-3 transcription factor in the carcinoma cell lines and found that the level of GATA-3 mRNA expression showed very good correlation with that of c-erbB-2 gene expression. This observation suggested that the GATA-3 transcription factor and c-erbB-2 protein play important roles in the process of immortalization and/or maintenance of the transformed phenotype of human esophageal carcinoma cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902061

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Chemoradiotherapy for esophageal cancer.

Authors:  Geoffrey Neuner; Ashish Patel; Mohan Suntharalingam
Journal:  Gastrointest Cancer Res       Date:  2009-03

3.  Differences between oral cancer and cancers of the pharynx and larynx on a molecular level.

Authors:  Kiyoto Shiga; Takenori Ogawa; Katsunori Katagiri; Fumiaki Yoshida; Masaru Tateda; Kazuto Matsuura; Toshimitsu Kobayashi
Journal:  Oncol Lett       Date:  2011-10-19       Impact factor: 2.967

4.  Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma.

Authors:  Patrapim Sunpaweravong; Somkiat Sunpaweravong; Puttisak Puttawibul; Winyou Mitarnun; Chan Zeng; Anna E Barón; Wilbur Franklin; Sherif Said; Marileila Varella-Garcia
Journal:  J Cancer Res Clin Oncol       Date:  2004-10-19       Impact factor: 4.553

5.  GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.

Authors:  Katherine U Gaynor; Irina V Grigorieva; Michael D Allen; Christopher T Esapa; Rosemary A Head; Preethi Gopinath; Paul T Christie; M Andrew Nesbit; J Louise Jones; Rajesh V Thakker
Journal:  Horm Cancer       Date:  2013-02-22       Impact factor: 3.869

6.  Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis.

Authors:  Renske D M Steenbergen; Vanessa E OudeEngberink; Debbie Kramer; Henri F J Schrijnemakers; Rene H M Verheijen; Chris J L M Meijer; Peter J F Snijders
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

7.  HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus.

Authors:  A N Khan; W Yang; A M Seifalian; M C Winslet
Journal:  Br J Cancer       Date:  2006-04-24       Impact factor: 7.640

8.  Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma.

Authors:  K Mimura; K Kono; M Hanawa; F Mitsui; H Sugai; N Miyagawa; A Ooi; H Fujii
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

9.  HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder.

Authors:  Z Latif; A D Watters; I Dunn; K M Grigor; M A Underwood; J M S Bartlett
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

10.  Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer.

Authors:  L Gibault; J-P Metges; V Conan-Charlet; P Lozac'h; M Robaszkiewicz; C Bessaguet; N Lagarde; A Volant
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.